{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:16:59Z","timestamp":1779333419268,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"S14","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12859-017-1895-2","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T03:30:09Z","timestamp":1514431809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development of models for predicting Torsade de Pointes cardiac arrhythmias using perceptron neural networks"],"prefix":"10.1186","volume":"18","author":[{"given":"Mohsen","family":"Sharifi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Buzatu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Wilkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"1895_CR1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.108.789081","volume":"2","author":"AO Grant","year":"2009","unstructured":"Grant AO. Cardiac ion channels. Circ Arrhythm Electrophysiol. 2009;2:185\u201394.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1895_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2015.03.003","volume":"86","author":"BO Villoutreix","year":"2015","unstructured":"Villoutreix BO, Taboureau O. Computational investigations of hERG channel blockers: new insights and current predictive models. Adv Drug Deliv Rev. 2015;86:72\u201382.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"1895_CR3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nrd2983","volume":"8","author":"H Wulff","year":"2009","unstructured":"Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov. 2009;8(12):982\u20131001.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"1895_CR4","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.febslet.2010.01.038","volume":"584","author":"I Szab\u00f2","year":"2010","unstructured":"Szab\u00f2 I, Zoratti M, Gulbins E. Contribution of voltage-gated potassium channels to the regulation of apoptosis. FEBS Lett. 2010;584(10):2049\u201356.","journal-title":"FEBS Lett"},{"key":"1895_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tips.2005.05.003","volume":"26","author":"SD Buckingham","year":"2005","unstructured":"Buckingham SD, Kidd JF, Law RJ, Franks CJ, Sattelle DB. Structure and function of two-pore-domain K+ channels: contributions from genetic model organisms. Trends Pharmacol Sci. 2005;26:361\u20137.","journal-title":"Trends Pharmacol Sci"},{"key":"1895_CR6","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","volume":"158","author":"A Glassman","year":"2001","unstructured":"Glassman A, Bigger T. Antipsychotic drugs: prolonged QTc interval, Torsade de Pointes, and sudden death. Am J Psychiatry. 2001;158:1774\u201382.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1895_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","volume":"91","author":"GR Mirams","year":"2011","unstructured":"Mirams GR, Cui Y, Sher A, Fink M, Cooper J, Heath BM, McMahon NC, Gavaghan DJ, Noble D. Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk. Cardiovasc Res. 2011;91(1):53\u201361.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"1895_CR8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","volume":"14","author":"EC Pearson","year":"2005","unstructured":"Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf. 2005;14(11):747\u201353.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1895_CR9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","volume":"50","author":"A Ferrari","year":"2004","unstructured":"Ferrari A, Coccia CP, Bertolini A, Sternieri E. Methadone-metabolism, pharmacokinetics and interactions. Pharmacol Res. 2004;50(6):551\u20139.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1895_CR10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199607253350416","volume":"335","author":"DK Wysowski","year":"1996","unstructured":"Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med. 1996;335(4):290\u20131.","journal-title":"N Engl J Med"},{"issue":"21","key":"1895_CR11","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1001\/jama.1990.03450210088038","volume":"264","author":"BP Monahan","year":"1990","unstructured":"Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR Jr. Torsades de pointes occurring in association with terfenadine use. JAMA. 1990;264(21):2788\u201390.","journal-title":"JAMA"},{"key":"1895_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/B978-012369520-8.50017-6","volume-title":"Drug-like properties: concepts, structure design and methods","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L. Chapter 16 \u2013 hERG Blocking. In: Drug-like properties: concepts, structure design and methods. London: Elsevier; 2008. p. 209\u201314."},{"key":"1895_CR13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"YG Yap","year":"2003","unstructured":"Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89:1363\u201372.","journal-title":"Heart"},{"issue":"3","key":"1895_CR14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005344-200403000-00007","volume":"43","author":"RL Martin","year":"2004","unstructured":"Martin RL, McDermott JS, Salmen HJ, Palmatier J, Cox BF, Gintant GA. The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block. J Cardiovasc Pharmacol. 2004;43(3):369\u201379.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"1895_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40264-013-0016-z","volume":"36","author":"N Stockbridge","year":"2013","unstructured":"Stockbridge N, Morganroth J, Shah RR, Garnett C. Dealing with global safety issues: was the response to QT-liability of non-cardiac drugs well coordinated? Drug Saf. 2013;36(3):167\u201382.","journal-title":"Drug Saf"},{"issue":"3","key":"1895_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2005.01.003","volume":"26","author":"MC Sanguinetti","year":"2005","unstructured":"Sanguinetti MC, Mitcheson JS. Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends Pharmacol Sci. 2005;26(3):119\u201324.","journal-title":"Trends Pharmacol Sci"},{"key":"1895_CR17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jmgm.2017.01.012","volume":"72","author":"IB Stoyanova-Slavova","year":"2017","unstructured":"Stoyanova-Slavova IB, Slavov SH, Buzatu DA, Beger RD, Wilkes JG. 3D-SDAR modeling of hERG potassium channel affinity: a case study in model design and toxicophore identification. J Mol Graph Model. 2017;72:246\u201355.","journal-title":"J Mol Graph Model"},{"key":"1895_CR18","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","volume":"3","author":"J Kramer","year":"2013","unstructured":"Kramer J, Obejero-Paz CA, Myatt G, Kuryshev YA, Bruening-Wright A, Verducci J, Brown AM. MICE models: superior to the HERG model in predicting Torsade de Pointes. Sci Rep. 2013;3:2100.","journal-title":"Sci Rep"},{"key":"1895_CR19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","volume":"58","author":"WS Redfern","year":"2003","unstructured":"Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003;58:32\u201345.","journal-title":"Cardiovasc Res"},{"key":"1895_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0003-2670(01)83100-7","volume":"103","author":"W Bremser","year":"1978","unstructured":"Bremser W. HOSE - a novel substructure code. Anal Chim Acta. 1978;103:355\u201365.","journal-title":"Anal Chim Acta"},{"issue":"2","key":"1895_CR21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/jmre.2002.2599","volume":"157","author":"J Meiler","year":"2002","unstructured":"Meiler J, Maier W, Will M, Meusinger R. Using neural networks for (13) C NMR chemical shift prediction-comparison with traditional methods. J Magn Reson. 2002;157(2):242\u201352.","journal-title":"J Magn Reson"},{"issue":"4","key":"1895_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10822-016-9909-0","volume":"30","author":"JG Wilkes","year":"2016","unstructured":"Wilkes JG, Stoyanova-Slavova IB, Buzatu DA. Alignment-independent technique for 3D QSAR analysis. J Comput Aided Mol Des. 2016;30(4):331\u201345.","journal-title":"J Comput Aided Mol Des"},{"key":"1895_CR23","volume-title":"STATISTICS methods and applications. A comprehensive reference for science, industry and data mining","author":"T Hill","year":"2006","unstructured":"Hill T, Lewicki P. STATISTICS methods and applications. A comprehensive reference for science, industry and data mining. 1st ed. Tulsa: StatSoft Inc; 2006.","edition":"1"},{"issue":"2","key":"1895_CR24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.301.2.427","volume":"301","author":"S Ekins","year":"2002","unstructured":"Ekins S, Crumb WJ, Sarazan RD, Wikel JH, Wrighton SA. Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. J Pharmacol Exp Ther. 2002;301(2):427\u201334.","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"1895_CR25","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/ci5001955","volume":"54","author":"JM Kratz","year":"2014","unstructured":"Kratz JM, Schuster D, Edtbauer M, Saxena P, Mair CE, Kirchebner J, Matuszczak B, Baburin I, Hering S, Rollinger JM. Experimentally validated HERG pharmacophore models as cardiotoxicity prediction tools. J Chem Inf Model. 2014;54(10):2887\u2013901.","journal-title":"J Chem Inf Model"},{"key":"1895_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0079-6468(08)70005-5","volume":"29","author":"TK Morgan Jr","year":"1992","unstructured":"Morgan TK Jr, Sullivan ME. An overview of class III electrophysiological agents: a new generation of antiarrhythmic therapy. Prog Med Chem. 1992;29:65\u2013108.","journal-title":"Prog Med Chem"},{"key":"1895_CR27","volume-title":"In silico modeling-pharmacophores and hERG channel models","author":"DJ Chadwick","year":"2005","unstructured":"Chadwick DJ, Goode J. The hERG cardiac potassium channel: structure, function and long QT syndrome. In: Recanatini M, Cavalli A, Masetti M, editors. In silico modeling-pharmacophores and hERG channel models. Chichester: John Wiley & Sons; 2005."},{"issue":"2","key":"1895_CR28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cmdc.200700221","volume":"3","author":"C Kramer","year":"2008","unstructured":"Kramer C, Beck B, Kriegl JM, Clark T. A composite model for HERG blockade. ChemMedChem. 2008;3(2):254\u201365.","journal-title":"ChemMedChem"},{"issue":"10","key":"1895_CR29","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0960-894X(03)00196-3","volume":"13","author":"RA Pearlstein","year":"2003","unstructured":"Pearlstein RA, Vaz RJ, Kang J, Chen XL, Preobrazhenskaya M, Shchekotikhin AE, Korolev AM, Lysenkova LN, Miroshnikova OV, Hendrix J, Rampe D. Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches. Bioorg Med Chem Lett. 2003;13(10):1829\u201335.","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"1895_CR30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/138620711795508322","volume":"14","author":"O Taboureau","year":"2011","unstructured":"Taboureau O, J\u00f8rgensen FS. In silico predictions of hERG channel blockers in drug discovery: from ligand-based and target-based approaches to systems chemical biology. Comb Chem High Throughput Screen. 2011;14(5):375\u201387.","journal-title":"Comb Chem High Throughput Screen"},{"key":"1895_CR31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jmgm.2017.06.012","volume":"76","author":"M Sharifi","year":"2017","unstructured":"Sharifi M. Computational approaches to understand the adverse drug effect on potassium, sodium and calcium channels for predicting TdP cardiac arrhythmias. J Mol Graph Model. 2017;76:152\u201360.","journal-title":"J Mol Graph Model"},{"key":"1895_CR32","volume-title":"Electrocardiogram provided by Dr. Pierre Taboulet at Saint-Louis Hospital (APHP), 1 Avenue. Claude Vellefaux 75010, Paris, France","author":"P Taboulet","year":"2017","unstructured":"Taboulet P. Electrocardiogram provided by Dr. Pierre Taboulet at Saint-Louis Hospital (APHP), 1 Avenue. Claude Vellefaux 75010, Paris, France. 2017. \nhttp:\/\/www.e-cardiogram.com\n\n\/ Accessed 15 May 2017."}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-017-1895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T03:33:21Z","timestamp":1514432001000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-017-1895-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"journal-issue":{"issue":"S14","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1186\/s12859-017-1895-2","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"497"}}